celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicīna hidrohlorīds - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiski līdzekļi - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
flamerio 50 mikrogrami/250 mikrogrami/devā inhalācijas pulveris, dozēts
elpen pharmaceutical co. inc (sa), greece - salmeterolum, fluticasoni propionas - inhalācijas pulveris, dozēts - 50 mikrogrami/250 mikrogrami/devā
flamerio 50 mikrogrami/500 mikrogrami/devā inhalācijas pulveris, dozēts
elpen pharmaceutical co. inc (sa), greece - salmeterolum, fluticasoni propionas - inhalācijas pulveris, dozēts - 50 mikrogrami/500 mikrogrami/devā
bortezomib pharmaswiss 3,5 mg pulveris injekciju šķīduma pagatavošanai
pharmaswiss ceska republika s.r.o., czech republic - bortezomibs - pulveris injekciju šķīduma pagatavošanai - 3,5 mg
quinapril polpharma 10 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - hinaprils - apvalkotās tabletes - 10 mg
quinapril polpharma 40 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - hinaprils - apvalkotās tabletes - 40 mg
quinapril polpharma 20 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - hinaprils - apvalkotās tabletes - 20 mg
metoprolol polpharma 23,75 mg ilgstošās darbības tabletes
pharmaceutical works polpharma sa, poland - metoprolola sukcināts - ilgstošās darbības tablete - 23,75 mg
metoprolol polpharma 190 mg ilgstošās darbības tabletes
pharmaceutical works polpharma sa, poland - metoprolola sukcināts - ilgstošās darbības tablete - 190 mg
atropine sopharma 1 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - atropini sulfas - Šķīdums injekcijām - 1 mg/ml